Holding(s) in Company

Summary by AI BETAClose X

UBS AG, through UBS Group AG, has acquired a significant stake in Renalytix PLC, now holding 6.600346% of the voting rights, equating to 28,844,745 shares. This acquisition crossed a notification threshold on April 21, 2026, and was formally reported on April 23, 2026. There were no financial instruments with similar economic effects or other financial instruments involved in this notification.

Disclaimer*

UK 100

Latest directors dealings